{"id":67725,"date":"2025-09-26T18:56:57","date_gmt":"2025-09-26T18:56:57","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=67725"},"modified":"2025-09-27T02:55:29","modified_gmt":"2025-09-27T02:55:29","slug":"analyst-ratings-usa-sept-26th-2025","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/","title":{"rendered":"Analyst Ratings USA: Sept 26th, 2025"},"content":{"rendered":"

Analyst Ratings (USA)<\/strong><\/a><\/h3>\n

The following are today\u2019s latest 159 analyst ratings tracked from muliple analysts for American listed and traded stocks:<\/strong><\/em><\/p>\n

\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

Accenture PLC (ACN):<\/strong> JPMorgan Chase lowered the target price from $302 to $290 while maintaining an Overweight rating, reflecting slightly more conservative revenue expectations.<\/p>\n

Accenture PLC (ACN):<\/strong> Deutsche Bank lowered the target price from $260 to $235 with a Hold rating, reflecting caution on near-term growth.<\/p>\n

Accenture PLC (ACN):<\/strong> TD Cowen lowered the target price from $313 to $295 with a Buy rating, reflecting moderate slowdown in consulting demand.<\/p>\n

Accenture PLC (ACN):<\/strong> Robert W. Baird lowered the target price from $350 to $330 with an Outperform rating, reflecting conservative outlook despite long-term potential.<\/p>\n

Accenture PLC (ACN):<\/strong> Guggenheim lowered the target price from $305 to $285 with a Buy rating, reflecting tempered revenue growth expectations.<\/p>\n

Accenture PLC (ACN):<\/strong> BMO Capital Markets set the target price at $270,\u00a0reflecting updated market assumptions.<\/p>\n

Accenture PLC (ACN):<\/strong> Royal Bank of Canada lowered the target price from $372 to $285 with an Outperform rating, reflecting valuation concerns amid slower growth.<\/p>\n

Accenture PLC (ACN):<\/strong> Cowen reiterated a Buy rating, reflecting confidence in long-term consulting opportunities.<\/p>\n

Accenture PLC (ACN):<\/strong> Goldman Sachs lowered the target price from $370 to $330 with a Buy rating, reflecting cautious near-term outlook.<\/p>\n

Accenture PLC (ACN):<\/strong> HSBC lowered the target price from $240 to $215, reflecting slower near-term revenue growth.<\/p>\n

American Airlines Group (AAL):<\/strong> UBS Group raised the target price from $12 to $13 while maintaining a Neutral rating, reflecting modest improvement in operational outlook.<\/p>\n

Americas Gold and Silver Corporation (USAS):<\/strong> Desjardins initiated coverage with a Buy rating at a stock price of $3.52.<\/p>\n

Allarity Therapeutics (ALLR):<\/strong> Ascendiant Capital Markets raised the target price from $9.00 to $9.25 with a Buy rating, reflecting positive clinical developments.<\/p>\n

Allstate (ALL):<\/strong> Roth Capital set a Buy rating with a $230 target, reflecting steady insurance growth and favorable market conditions.<\/p>\n

Allegiant Travel (ALGT):<\/strong> UBS Group raised the target price from $52 to $65 with a Neutral rating, reflecting improved travel demand and operational outlook.<\/p>\n

Alkermes plc (ALKS):<\/strong> Royal Bank of Canada upgraded the rating from Sector Perform to Outperform and raised the target price from $42 to $44, reflecting stronger pipeline and revenue growth expectations.<\/p>\n

Amgen Inc. (AMGN):<\/strong> Bank of America raised the target price from $261 to $272 but maintained an Underperform rating, reflecting valuation concerns despite pipeline progress.<\/p>\n

Apellis Pharmaceuticals (APLS):<\/strong> Goldman Sachs downgraded the rating from Neutral to Sell and cut the target price from $26 to $18, reflecting disappointing product performance or market headwinds.<\/p>\n

AppLovin Corporation (APP):<\/strong> UBS Group raised the target price from $540 to $810 with a Buy rating, reflecting strong user growth and advertising monetization.<\/p>\n

AppLovin Corporation (APP):<\/strong> Piper Sandler raised the target price from $500 to $740 with an Overweight rating, reflecting improved digital ad revenue trends.<\/p>\n

Atmos Energy (ATO):<\/strong> Mizuho raised the target price from $164 to $170 with a Neutral rating, reflecting stable utility operations.<\/p>\n

Atome Plc (ATOM):<\/strong> Canaccord Genuity Group raised the target price from GBX 130 to GBX 140 with a Speculative Buy rating, reflecting growth potential in e-commerce.<\/p>\n

Babcock International Group (BAB):<\/strong> Berenberg Bank raised the target price from GBX 1,360 to GBX 1,440 with a Buy rating, reflecting stronger contract wins and margin improvement.<\/p>\n

Braskem S.A. (BAK):<\/strong> UBS Group downgraded the rating from Buy to Neutral and lowered the target price from $5.10 to $3.80, reflecting weaker commodity market expectations.<\/p>\n

BlackBerry Limited (BB):<\/strong> Canaccord Genuity Group reiterated a Hold rating at $4.60, reflecting steady software revenue but limited upside.<\/p>\n

BlackBerry Limited (BB):<\/strong> Royal Bank of Canada set the target price at $4.50, reflecting cautious outlook on turnaround.<\/p>\n

BlackBerry Limited (BB):<\/strong> Robert W. Baird raised the target price from $5.00 to $5.50 with a Neutral rating, reflecting optimism on software and security solutions.<\/p>\n

Brookfield Business Partners L.P. (BBU):<\/strong> Scotiabank raised the target price from $36 to $39 with a Sector Outperform rating, reflecting portfolio growth and infrastructure opportunities.<\/p>\n

Brookfield Business Partners L.P. (BBU):<\/strong> Scotiabank reiterated an Outperform rating, reflecting stable long-term fundamentals.<\/p>\n

Brookfield Renewable Partners L.P. (BEP):<\/strong> Mizuho raised the target price from $26 to $27 with a Neutral rating, reflecting renewable energy growth and steady cash flows.<\/p>\n

Brookfield Infrastructure Partners LP (BIP):<\/strong> National Bankshares set an Outperform rating with a $35 target, reflecting strong infrastructure investment potential.<\/p>\n

Birkenstock Holding PLC (BIRK):<\/strong> Telsey Advisory Group reiterated an Outperform rating at $70, reflecting strong brand growth and retail demand.<\/p>\n

Cidara Therapeutics (CDTX):<\/strong> HC Wainwright raised the target price from $74 to $110 with a Buy rating, reflecting promising clinical developments.<\/p>\n

CG Oncology (CGON):<\/strong> JPMorgan Chase raised the target price from $41 to $47 with an Overweight rating, reflecting favorable clinical progress.<\/p>\n

Ciena Corporation (CIEN):<\/strong> Rosenblatt Securities upgraded the rating from Neutral to Buy and raised the target price from $127.50 to $175, reflecting stronger demand for networking solutions.<\/p>\n

Cipher Mining (CIFR):<\/strong> JPMorgan Chase raised the target price from $6 to $12 with a Neutral rating, reflecting improved cryptocurrency mining outlook.<\/p>\n

Cleanspark (CLSK):<\/strong> JPMorgan Chase reiterated the rating with the target price lowered from $15 to $14, reflecting moderation in clean energy solutions growth.<\/p>\n

Costco Wholesale (COST):<\/strong> JPMorgan Chase lowered the target price from $1,160 to $1,050 with an Overweight rating, reflecting slower near-term retail sales.<\/p>\n

Costco Wholesale (COST):<\/strong> Goldman Sachs raised the target price from $1,333 to $1,418 with a Buy rating, reflecting stronger long-term fundamentals.<\/p>\n

Costco Wholesale (COST):<\/strong> DA Davidson reiterated a Neutral rating at $1,000, reflecting steady performance.<\/p>\n

Costco Wholesale (COST):<\/strong> Truist Financial lowered the target price from $1,042 to $1,033 with a Hold rating, reflecting moderate near-term pressures.<\/p>\n

Costco Wholesale (COST):<\/strong> Evercore ISI lowered the target price from $1,060 to $1,025 with an Outperform rating, reflecting cautious sales outlook..<\/p>\n

Costco Wholesale (COST):<\/strong> Oppenheimer reiterated an Outperform rating at $1,130, reflecting confidence in Costco\u2019s long-term growth potential and stable membership-driven revenue.<\/p>\n

Costco Wholesale (COST):<\/strong> Morgan Stanley lowered the target price from $1,225 to $1,130 with an Overweight rating, reflecting moderation in near-term retail sales and cautious outlook on margin expansion.<\/p>\n

Costco Wholesale (COST):<\/strong> Roth Capital set the target price at $907 with a Neutral rating, reflecting concerns about near-term cost pressures and slower sales growth.<\/p>\n

Costco Wholesale (COST):<\/strong> Sanford C. Bernstein raised the target price slightly from $1,137 to $1,140 with an Outperform rating, reflecting steady fundamentals and continued confidence in Costco\u2019s membership-based model.<\/p>\n

CRH (CRH):<\/strong> Bank of America initiated coverage with a Buy rating at $128, reflecting growth in construction materials.<\/p>\n

Crinetics Pharmaceuticals (CRNX):<\/strong> Robert W. Baird raised the target price from $58 to $62 with an Outperform rating, reflecting positive clinical data.<\/p>\n

Crinetics Pharmaceuticals (CRNX):<\/strong> Goldman Sachs raised the target price from $35 to $40 with a Neutral rating, reflecting cautious optimism.<\/p>\n

Crinetics Pharmaceuticals (CRNX):<\/strong> JMP Securities raised the target price from $86 to $143 with a Market Outperform rating, reflecting strong pipeline potential.<\/p>\n

CSX (CSX):<\/strong> Robert W. Baird lowered the target price from $44 to $39 with an Outperform rating, reflecting near-term transportation demand concerns.<\/p>\n

Cintas (CTAS):<\/strong> Citigroup raised the target price from $172 to $176 with a Sell rating, reflecting valuation concerns despite solid operations.<\/p>\n

Camping World (CWH):<\/strong> Citigroup raised the target price from $21 to $22 with a Buy rating, reflecting improving retail conditions.<\/p>\n

Dave Inc. (DAVE):<\/strong> Citizens JMP and JMP Securities raised the target price from $280 to $300 with a Market Outperform rating, reflecting growth in fintech operations.<\/p>\n

DeFi Technologies (DEFT):<\/strong> HC Wainwright reiterated a Buy rating at $5.50, reflecting continued exposure to decentralized finance growth.<\/p>\n

DENTSPLY SIRONA Inc. (XRAY):<\/strong> Needham & Company LLC reiterated a Hold rating, reflecting steady dental equipment demand with limited near-term catalysts.<\/p>\n

Dollar General (DG):<\/strong> Gordon Haskett lowered the target price from $130 to $115, reflecting moderate retail headwinds.<\/p>\n

DICK\u2019S Sporting Goods (DKS):<\/strong> BNP Paribas initiated coverage with an Underperform rating at $177, reflecting cautious retail outlook.<\/p>\n

Duke Energy (DUK):<\/strong> Jefferies downgraded from Buy to Hold and lowered the target price from $141 to $134, reflecting slower utility growth.<\/p>\n

DexCom (DXCM):<\/strong> Robert W. Baird lowered the target price from $112 to $90 with an Outperform rating, reflecting moderation in diabetes device demand.<\/p>\n

Dycom Industries (DY):<\/strong> Wells Fargo raised the target price from $295 to $305 with an Overweight rating, reflecting stronger infrastructure services demand.<\/p>\n

Electronic Arts (EA):<\/strong> Citigroup reiterated a Neutral rating, reflecting steady gaming performance.<\/p>\n

Enlivex Therapeutics (ENLV):<\/strong> D. Boral Capital reiterated a Buy rating at $13, reflecting ongoing positive clinical pipeline developments.<\/p>\n

EnQuest (ENQ):<\/strong> Canaccord Genuity raised the target price from GBX 19 to GBX 20 with a Buy rating, reflecting improving oil production outlook.<\/p>\n

EOG Resources (EOG):<\/strong> Scotiabank reiterated the rating with Sector Perform, reflecting stable energy production and commodity exposure.<\/p>\n

Freeport-McMoRan (FCX):<\/strong> CICC Research lowered the target price from $51.60 to $42.30 with an Outperform rating, reflecting weaker copper and gold price assumptions.<\/p>\n

First Horizon (FHN):<\/strong> DA Davidson initiated a Neutral rating at $24, reflecting steady banking fundamentals.<\/p>\n

Fox Corporation (FOXA):<\/strong> Bank of America raised the target price from $65 to $70 with a Buy rating, reflecting strong media revenue outlook.<\/p>\n

Fox Corporation (FOXA):<\/strong> Guggenheim raised the target price from $62 to $68 with a Buy rating, reflecting optimism on advertising and streaming growth.<\/p>\n

First Merchants (FRME):<\/strong> Raymond James downgraded the rating from Outperform to Market Perform, reflecting moderate banking headwinds.<\/p>\n

First Merchants (FRME):<\/strong> Keefe, Bruyette & Woods raised the target price from $49 to $50 with an Outperform rating, reflecting stable financial performance.<\/p>\n

H.B. Fuller (FUL):<\/strong> Citigroup lowered the target price from $70 to $62 with a Neutral rating, reflecting softer near-term industrial demand.<\/p>\n

Guardant Health (GH):<\/strong> Canaccord Genuity raised the target price from $65 to $75 with a Buy rating, reflecting strong diagnostic test adoption.<\/p>\n

Glenveagh Properties (GLV):<\/strong> Deutsche Bank upgraded to a Buy rating, reflecting residential property growth potential.<\/p>\n

Genco Shipping & Trading (GNK):<\/strong> SEB Equity Research set the target price at $23, reflecting steady shipping market expectations.<\/p>\n

GeoVax Labs (GOVX):<\/strong> D. Boral Capital reiterated a Buy rating at $9, reflecting ongoing vaccine development.<\/p>\n

Guardian Pharmacy Services (GRDN):<\/strong> Truist Financial raised the target price from $28 to $30 with a Buy rating, reflecting expansion in pharmacy operations.<\/p>\n

Heritage Financial (HFWA):<\/strong> DA Davidson reiterated a Buy rating at $28, reflecting steady banking performance.<\/p>\n

Halma (HLMA):<\/strong> Shore Capital reiterated a Hold rating at GBX 3,352, reflecting stable industrial technology demand.<\/p>\n

Intercontinental Hotels Group (IHG):<\/strong> JPMorgan Chase upgraded the rating from Neutral to Overweight, reflecting recovery in hospitality demand.<\/p>\n

Immuneering (IMRX):<\/strong> Chardan Capital raised the target price from $13 to $20 with a Buy rating, reflecting promising therapeutics pipeline.<\/p>\n

Immunic (IMUX):<\/strong> HC Wainwright reiterated a Buy rating at $10, reflecting steady clinical development.<\/p>\n

Ionis Pharmaceuticals (IONS):<\/strong> Goldman Sachs upgraded the rating from Sell to Neutral and raised the target price from $45 to $65, reflecting stronger pipeline visibility.<\/p>\n

IREN Limited (IREN):<\/strong> JPMorgan Chase reiterated the rating, downgraded from Neutral to Underweight, and raised the target price from $16 to $24, reflecting operational and market risks.<\/p>\n

Jabil (JBL):<\/strong> Barclays raised the target price from $223 to $267 with an Overweight rating, reflecting electronics manufacturing demand.<\/p>\n

JD.com (JD):<\/strong> Arete Research initiated coverage at $41, reflecting e-commerce potential.<\/p>\n

JD.com (JD):<\/strong> Arete upgraded the rating from Sell to Buy, reflecting stronger online retail performance.<\/p>\n

Johnson Service Group (JSG):<\/strong> Berenberg Bank reiterated a Buy rating at GBX 195, reflecting steady business services demand.<\/p>\n

Kenvue Inc. (KVUE):<\/strong> Redburn Partners set the target price at $22.00, reflecting initial confidence in near-term stability and product pipeline potential.<\/p>\n

Kenvue Inc. (KVUE):<\/strong> Rothschild & Co Redburn upgraded the rating from Neutral to Buy and adjusted the target price from $22.00 to $22.50, reflecting stronger growth outlook and improved market positioning.<\/p>\n

Klaviyo, Inc. (KVYO):<\/strong> Stephens lowered the target price from $45.00 to $43.00 and maintained an Overweight rating, reflecting tempered near-term growth expectations in marketing automation demand.<\/p>\n

Klaviyo, Inc. (KVYO):<\/strong> Piper Sandler reiterated an Overweight rating and lowered the target price from $55.00 to $50.00, reflecting more cautious guidance on customer acquisition trends.<\/p>\n

Klaviyo, Inc. (KVYO):<\/strong> Robert W. Baird lowered the target price from $44.00 to $39.00 and maintained an Outperform rating, reflecting moderation in revenue growth expectations while remaining confident in long-term market share gains.<\/p>\n

Klaviyo, Inc. (KVYO):<\/strong> Needham & Company LLC reiterated a Buy rating with a target price of $45.00, reflecting confidence in sustainable growth potential and client retention.<\/p>\n

Kratos Defense & Security Solutions, Inc. (KTOS):<\/strong> Robert W. Baird raised the target price from $70.00 to $87.00 and maintained an Outperform rating, reflecting optimism in defense contracts and government spending growth.<\/p>\n

Levi Strauss & Co. (LEVI):<\/strong> Barclays raised the target price from $24.00 to $26.00 and maintained an Overweight rating, reflecting stronger retail demand and positive brand momentum.<\/p>\n

LightPath Technologies, Inc. (LPTH):<\/strong> Lake Street Capital raised the target price from $4.00 to $7.50 and maintained a Buy rating, reflecting improved product adoption and expected revenue growth.<\/p>\n

LightPath Technologies, Inc. (LPTH):<\/strong> HC Wainwright raised the target price from $7.00 to $8.00 and maintained a Buy rating, reflecting increasing market traction and expanding client base.<\/p>\n

Live Nation Entertainment, Inc. (LYV):<\/strong> Benchmark raised the target price from $180.00 to $190.00 and maintained a Buy rating, reflecting growing concert attendance and post-pandemic recovery in live events.<\/p>\n

Macerich Company (MAC):<\/strong> Bank of America upgraded the rating from Neutral to Buy and raised the target price from $19.00 to $23.00, reflecting improving retail property fundamentals and leasing activity.<\/p>\n

Marathon Digital Holdings, Inc. (MARA):<\/strong> JPMorgan Chase & Co. lowered the target price from $22.00 to $20.00 and maintained an Overweight rating, reflecting short-term volatility in cryptocurrency prices while maintaining long-term operational confidence.<\/p>\n

Marathon Petroleum Corporation (MPC):<\/strong> UBS Group raised the target price from $203.00 to $220.00 and maintained a Buy rating, reflecting strong refining margins and improved operational efficiency.<\/p>\n

McKesson Corporation (MCK):<\/strong> JPMorgan Chase & Co. raised the target price from $821.00 to $853.00 and maintained an Overweight rating, reflecting steady pharmaceutical distribution growth and resilient healthcare demand.<\/p>\n

Magnite, Inc. (MGNI):<\/strong> Rosenblatt Securities reiterated a Buy rating with a target price of $39.00, reflecting confidence in digital advertising demand and programmatic platform growth.<\/p>\n

Methanex Corporation (MEOH):<\/strong> National Bank Financial initiated coverage with an Outperform rating and set a target price of $47.00, reflecting optimism on methanol market demand and margin stability.<\/p>\n

Mirion Technologies, Inc. (MIR):<\/strong> JPMorgan Chase & Co. initiated coverage with an Overweight rating and set a target price of $28.00, reflecting confidence in nuclear measurement solutions growth and contract wins.<\/p>\n

Microsoft Corporation (MSFT):<\/strong> Morgan Stanley raised the target price from $582.00 to $625.00 and maintained an Overweight rating, reflecting strong cloud adoption, AI integration, and stable enterprise revenue growth.<\/p>\n

Mondelez International, Inc. (MDLZ):<\/strong> Evercore ISI lowered the target price from $73.00 to $72.00 and maintained an Outperform rating, reflecting slower near-term revenue growth while maintaining confidence in long-term brand strength.<\/p>\n

Morgan Stanley (MS):<\/strong> Citigroup raised the target price from $130.00 to $155.00 and maintained a Neutral rating, reflecting improved capital market activity and earnings stability.<\/p>\n

ONE Gas, Inc. (OGS):<\/strong> Mizuho upgraded the rating from Neutral to Outperform and raised the target price from $77.00 to $86.00, reflecting stronger utility performance and stable earnings outlook.<\/p>\n

Okta, Inc. (OKTA):<\/strong> Royal Bank of Canada reiterated an Outperform rating with a target price of $115.00, reflecting confidence in cybersecurity demand and enterprise adoption.<\/p>\n

Okta, Inc. (OKTA):<\/strong> BTIG Research reiterated a Buy rating with a target price of $142.00, reflecting long-term growth in identity management solutions.<\/p>\n

Okta, Inc. (OKTA):<\/strong> DA Davidson reiterated a Buy rating with a target price of $140.00, reflecting continued enterprise demand and subscription revenue stability.<\/p>\n

Oracle Corporation (ORCL):<\/strong> UBS Group set the target price at $364.00, reflecting confidence in cloud business growth and strong enterprise software demand.<\/p>\n

Oracle Corporation (ORCL):<\/strong> Sanford C. Bernstein raised the target price from $363.00 to $364.00 and maintained an Outperform rating, reflecting robust cloud adoption and strong earnings visibility.<\/p>\n

Organogenesis (ORGO):<\/strong> BTIG Research reiterated a Buy rating with a target price of $7.00, reflecting continued demand for regenerative medicine products.<\/p>\n

OSI Systems, Inc. (OSIS):<\/strong> Bank of America raised the target price from $250.00 to $265.00 and maintained a Buy rating, reflecting solid performance in security and healthcare solutions.<\/p>\n

Palo Alto Networks, Inc. (PANW):<\/strong> UBS Group set the target price at $245.00, reflecting strong cybersecurity demand and enterprise adoption trends.<\/p>\n

Palo Alto Networks, Inc. (PANW):<\/strong> Tigress Financial initiated coverage with a Buy rating and set a target price of $245.00, reflecting strong long-term growth potential in network security solutions.<\/p>\n

Palvella Therapeutics, Inc. (PVLA):<\/strong> Chardan Capital raised the target price from $60.00 to $73.00 and maintained a Buy rating, reflecting promising clinical development milestones.<\/p>\n

Paycom Software, Inc. (PAYC):<\/strong> Guggenheim initiated coverage with a Buy rating and set a target price of $270.00, reflecting strong HR technology adoption and consistent revenue growth.<\/p>\n

Paychex, Inc. (PAYX):<\/strong> Wolfe Research lowered the target price from $145.00 to $140.00 and maintained an Underperform rating, reflecting slowing small-business payroll trends and cautious near-term guidance.<\/p>\n

Poolbeg Pharma PLC (POLB):<\/strong> Shore Capital reiterated the rating at GBX 3.89, reflecting continued clinical development with moderate near-term catalysts.<\/p>\n

Pure Storage, Inc. (PSTG):<\/strong> Wells Fargo & Company raised the target price from $80.00 to $100.00 and maintained an Overweight rating, reflecting increasing demand for flash storage and cloud solutions.<\/p>\n

Pure Storage, Inc. (PSTG):<\/strong> Evercore ISI raised the target price from $85.00 to $90.00 and maintained an Outperform rating, reflecting stronger enterprise adoption and revenue visibility.<\/p>\n

Pure Storage, Inc. (PSTG):<\/strong> Guggenheim raised the target price from $93.00 to $105.00 and maintained a Buy rating, reflecting optimism about long-term growth in storage solutions.<\/p>\n

Pure Storage, Inc. (PSTG):<\/strong> Needham & Company LLC raised the target price from $85.00 to $100.00 and maintained a Buy rating, reflecting confidence in recurring revenue and expanding enterprise adoption.<\/p>\n

Quince Therapeutics, Inc. (QNCX):<\/strong> D. Boral Capital reiterated a Buy rating with a target price of $4.00, reflecting optimism on ongoing clinical programs.<\/p>\n

Rapt Therapeutics (RAPT):<\/strong> Leerink Partners upgraded the rating from Market Perform to Outperform and raised the target price from $16.00 to $37.00, reflecting positive clinical trial results and pipeline potential.<\/p>\n

Ralph Lauren Corporation (RL):<\/strong> JPMorgan Chase & Co. raised the target price from $423.00 to $430.00 and maintained an Overweight rating, reflecting strong brand positioning and recovery in retail sales.<\/p>\n

Redwood Trust, Inc. (RWT):<\/strong> BTIG Research reiterated a Buy rating with a target price of $8.50, reflecting confidence in mortgage REIT performance and yield potential.<\/p>\n

Rollins, Inc. (ROL):<\/strong> JPMorgan Chase & Co. initiated coverage with an Overweight rating and set a target price of $70.00, reflecting steady pest control service growth and recurring revenue.<\/p>\n

Seplat Energy Plc (SEPL):<\/strong> Canaccord Genuity Group raised the target price from GBX 465 to GBX 550 and maintained a Buy rating, reflecting positive upstream production outlook and commodity price support.<\/p>\n

TD SYNNEX Corporation (SNX):<\/strong> Barclays raised the target price from $140.00 to $164.00 and maintained an Equal Weight rating, reflecting balanced risk\/reward in IT distribution growth.<\/p>\n

TD SYNNEX Corporation (SNX):<\/strong> Morgan Stanley raised the target price from $173.00 to $181.00 and maintained an Overweight rating, reflecting confidence in IT services demand and distribution efficiency.<\/p>\n

TD SYNNEX Corporation (SNX):<\/strong> Bank of America raised the target price from $170.00 to $180.00 and maintained a Buy rating, reflecting strong growth in technology distribution and enterprise services.<\/p>\n

TD SYNNEX Corporation (SNX):<\/strong> Royal Bank of Canada raised the target price from $165.00 to $180.00 and maintained an Outperform rating, reflecting improving technology product demand and distribution leverage.<\/p>\n

Spyre Therapeutics, Inc. (SYRE):<\/strong> Deutsche Bank Aktiengesellschaft initiated coverage with a Buy rating and set a target price of $43.00, reflecting optimism on clinical trial progress and oncology pipeline potential.<\/p>\n

Tempus AI, Inc. (TEM):<\/strong> Guggenheim raised the target price from $80.00 to $95.00 and maintained a Buy rating, reflecting growth in AI-driven healthcare data analytics adoption.<\/p>\n

Thor Industries, Inc. (THO):<\/strong> BMO Capital Markets reiterated an Outperform rating, reflecting continued demand in recreational vehicle markets.<\/p>\n

Thor Industries, Inc. (THO):<\/strong> Citigroup raised the target price from $112.00 to $122.00 and maintained a Neutral rating, reflecting moderate near-term market challenges despite steady fundamentals.<\/p>\n

Tesla, Inc. (TSLA):<\/strong> Wedbush raised the target price from $500.00 to $600.00 and maintained an Outperform rating, reflecting growth in EV deliveries and energy storage adoption.<\/p>\n

Tesla, Inc. (TSLA):<\/strong> Royal Bank of Canada reiterated a Buy rating, reflecting strong EV market position and production expansion.<\/p>\n

Tesla, Inc. (TSLA):<\/strong> Deutsche Bank Aktiengesellschaft raised the target price from $345.00 to $435.00 and maintained a Buy rating, reflecting solid demand for EVs and confidence in cost efficiencies.<\/p>\n

Tetra Technologies, Inc. (TTI):<\/strong> Northland Securities set the target price at $7.00, reflecting stable operations in oilfield services and moderate near-term growth.<\/p>\n

Twilio Inc. (TWLO):<\/strong> Rosenblatt Securities reiterated a Buy rating with a target price of $140.00, reflecting continued growth in cloud communication APIs.<\/p>\n

United Airlines Holdings Inc (UAL):<\/strong> UBS Group raised the target price from $114.00 to $131.00 and maintained a Buy rating, reflecting recovery in travel demand and operational efficiency improvements.<\/p>\n

United States Antimony Co. (UAMY):<\/strong> HC Wainwright raised the target price from $4.50 to $8.50 and maintained a Buy rating, reflecting improving commodity pricing and production expansion.<\/p>\n

United Therapeutics Corporation (UTHR):<\/strong> Royal Bank of Canada initiated coverage with an Outperform rating and set a target price of $569.00, reflecting growth in rare disease treatments and pipeline potential.<\/p>\n

Ultrapar Participacoes S.A. (UGP):<\/strong> Goldman Sachs raised the target price from $4.00 to $4.50 and maintained a Buy rating, reflecting stable downstream energy operations and margin improvement.<\/p>\n

Uranium Energy Corp. (UEC):<\/strong> Goldman Sachs raised the target price from $13.00 to $17.00 and maintained a Buy rating, reflecting optimism on uranium pricing and production potential.<\/p>\n

Valmont Industries, Inc. (VMI):<\/strong> JPMorgan Chase & Co. initiated coverage with an Overweight rating and set a target price of $480.00, reflecting strong infrastructure demand and project backlog visibility.<\/p>\n

Vertex, Inc. (VERX):<\/strong> Stephens initiated coverage with an Overweight rating and set a target price of $30.00, reflecting confidence in dermatology drug growth and pipeline potential.<\/p>\n

Vail Resorts, Inc. (MTN):<\/strong> Morgan Stanley reiterated a Cautious rating, reflecting near-term tourism uncertainty and winter season variability.<\/p>\n

Vail Resorts, Inc. (MTN):<\/strong> Morgan Stanley raised the target price from $146.00 to $155.00 and issued an Equal Weight rating, reflecting solid recovery in visitor numbers while maintaining cautious outlook on discretionary spending.<\/p>\n

Warner Bros. Discovery, Inc. (WBD):<\/strong> KeyCorp reiterated an Overweight rating and changed it to Sector Weight, reflecting mixed media market trends and integration risks.<\/p>\n

Western Copper & Gold Corp (WRN):<\/strong> HC Wainwright raised the target price from $4.00 to $4.25 and maintained a Buy rating, reflecting positive exploration results and copper market potential.<\/p>\n

WhiteFiber, Inc. (WYFI):<\/strong> Macquarie raised the target price from $28.00 to $32.00 and maintained an Outperform rating, reflecting confidence in fiber optic expansion and revenue growth.<\/p>\n

Wix.com Ltd. (WIX):<\/strong> Piper Sandler raised the target price from $206.00 to $210.00 and maintained an Overweight rating, reflecting ongoing growth in website building and SaaS subscription revenues.<\/p>\n

\"Top Canadian Analyst Ratings:<\/em><\/a><\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/article>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings (USA) The following are today\u2019s latest 159 analyst ratings tracked from muliple analysts for American listed and traded stocks: Accenture PLC (ACN): JPMorgan…<\/p>\n","protected":false},"author":3,"featured_media":42760,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"image","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-67725","post","type-post","status-publish","format-image","has-post-thumbnail","hentry","category-blog","post_format-post-format-image"],"acf":[],"yoast_head":"\nAnalyst Ratings USA: Sept 26th, 2025 | Stock Target Advisor<\/title>\n<meta name=\"description\" content=\"Analyst Ratings fo Friday September 26th, 2025, Tesla, Apple and Microsoft\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Analyst Ratings USA: Sept 26th, 2025\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings fo Friday September 26th, 2025, Tesla, Apple and Microsoft\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-26T18:56:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-27T02:55:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/11\/JD.com-Stock-Gains-on-Impressive-Q3-Results.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"17 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"Analyst Ratings USA: Sept 26th, 2025\",\"datePublished\":\"2025-09-26T18:56:57+00:00\",\"dateModified\":\"2025-09-27T02:55:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/\"},\"wordCount\":3548,\"commentCount\":1,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/\",\"name\":\"Analyst Ratings USA: Sept 26th, 2025 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2025-09-26T18:56:57+00:00\",\"dateModified\":\"2025-09-27T02:55:29+00:00\",\"description\":\"Analyst Ratings fo Friday September 26th, 2025, Tesla, Apple and Microsoft\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Analyst Ratings USA: Sept 26th, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Analyst Ratings USA: Sept 26th, 2025 | Stock Target Advisor","description":"Analyst Ratings fo Friday September 26th, 2025, Tesla, Apple and Microsoft","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/","og_locale":"en_US","og_type":"article","og_title":"Analyst Ratings USA: Sept 26th, 2025","og_description":"Analyst Ratings fo Friday September 26th, 2025, Tesla, Apple and Microsoft","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2025-09-26T18:56:57+00:00","article_modified_time":"2025-09-27T02:55:29+00:00","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2023\/11\/JD.com-Stock-Gains-on-Impressive-Q3-Results.jpg","type":"image\/jpeg"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"17 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"Analyst Ratings USA: Sept 26th, 2025","datePublished":"2025-09-26T18:56:57+00:00","dateModified":"2025-09-27T02:55:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/"},"wordCount":3548,"commentCount":1,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/","name":"Analyst Ratings USA: Sept 26th, 2025 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2025-09-26T18:56:57+00:00","dateModified":"2025-09-27T02:55:29+00:00","description":"Analyst Ratings fo Friday September 26th, 2025, Tesla, Apple and Microsoft","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/analyst-ratings-usa-sept-26th-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Analyst Ratings USA: Sept 26th, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/67725","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=67725"}],"version-history":[{"count":7,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/67725\/revisions"}],"predecessor-version":[{"id":67754,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/67725\/revisions\/67754"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/42760"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=67725"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=67725"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=67725"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}